Deep integration of low-cost liquid handling robots in an industrial pharmaceutical development environment.

Automated Liquid Handlers (ALHs) Device Integration Digitalization in Laboratories FAIR Data Laboratory Automation OT-2 Liquid Handling Robot Pharmaceutical Research SiLA Standard Workflow Orchestration

Journal

SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564

Informations de publication

Date de publication:
31 Aug 2024
Historique:
received: 12 03 2024
revised: 02 08 2024
accepted: 26 08 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 2 9 2024
Statut: aheadofprint

Résumé

The pharmaceutical industry is increasingly embracing laboratory automation to enhance experimental efficiency and operational resilience, particularly through the integration of automated liquid handlers (ALHs). This paper explores the integration of the low-cost Opentrons OT-2 liquid handling robot with F. Hoffmann-La Roche AG's in-house workflow orchestration software, AutoLab, to overcome barriers to lab automation. By leveraging the OT-2's development-oriented interfaces and AutoLab's modular architecture, we achieved a user-friendly, cost-efficient, and flexible automation solution that aligns with FAIR (findable, accessible, interoperable, reusable) data principles. We demonstrate an advanced workflow development methodology, utilizing the software architecture, that facilitates the creation of two flexible pipetting protocols and medium complexity assays. This deep integration approach diminishes the learning curve for novice users while simultaneously enhancing the overall efficiency and reliability of the experimental workflow. Our findings suggest that such integrations can significantly mitigate the challenges associated with lab automation, including cost, complexity, and adaptability, paving the way for more accessible and robust automated systems in pharmaceutical research.

Identifiants

pubmed: 39222913
pii: S2472-6303(24)00062-1
doi: 10.1016/j.slast.2024.100180
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100180

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: All authors are employees or contractors at F. Hoffmann-La Roche AG If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anton Thieme (A)

F Hoffmann-La Roche AG.

Sean Renwick (S)

F Hoffmann-La Roche AG.

Michaela Marschmann (M)

F Hoffmann-La Roche AG.

Susanne Weissenborn (S)

F Hoffmann-La Roche AG.

Jamie Clifton (J)

F. Hoffmann-La Roche Ltd. Electronic address: jamie.clifton@roche.com.

Classifications MeSH